Cargando…
Early immune surveillance to predict cytomegalovirus outcomes after allogeneic hematopoietic stem cell transplantation
BACKGROUND: There is no method of predicting human cytomegalovirus (HCMV) outcomes in allogeneic hematopoietic stem cell transplant recipients clinically, leading in some cases to excessive or insufficient antiviral therapy. We evaluated the early immune response of recipients with disparate HCMV ou...
Autores principales: | Xia, Jintao, Li, Xuejie, Gui, Genyong, Wu, Jian, Gong, Shengnan, Shang, Yuxin, Fan, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382130/ https://www.ncbi.nlm.nih.gov/pubmed/35992173 http://dx.doi.org/10.3389/fcimb.2022.954420 |
Ejemplares similares
-
Features of cytomegalovirus infection and evaluation of cytomegalovirus-specific T cells therapy in children’s patients following allogeneic hematopoietic stem cell transplantation: A retrospective single-center study
por: Ruan, Yongsheng, et al.
Publicado: (2022) -
Insufficient Antigen Presentation Due to Viral Immune Evasion Explains Lethal Cytomegalovirus Organ Disease After Allogeneic Hematopoietic Cell Transplantation
por: Holtappels, Rafaela, et al.
Publicado: (2020) -
Profiling the Blood Compartment of Hematopoietic Stem Cell Transplant Patients During Human Cytomegalovirus Reactivation
por: Bernshtein, Biana, et al.
Publicado: (2021) -
Association Between Cytomegalovirus and Epstein-Barr Virus Co-Reactivation and Hematopoietic Stem Cell Transplantation
por: Li, Shan-shan, et al.
Publicado: (2022) -
Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience
por: Busca, Alessandro, et al.
Publicado: (2022)